Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The Role of the Wnt/β-Catenin Signaling Pathway in the Pathogenesis and Treatment of Spinal Cord Injury: A Review of the Latest Experimental Data

Fellouri G., Savvas K., Tsoutsi N., Kourtis E., Fanourgiakis I., Lepetsos P.

Narrative Review on Spinal Cord Injury, Scar, published in Cureus (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Cureus (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40799869
PMCID
PMC12341850
DOI
10.7759/cureus.87836
Citations
2

Abstract (original English)

Spinal cord injury (SCI) is a debilitating condition with a high incidence, leading to irreversible motor, sensory, and autonomic dysfunctions. Despite significant advances in understanding the pathophysiology of SCI, effective therapeutic strategies for regeneration remain elusive. The Wnt/β-catenin signaling pathway has emerged as a key player in various developmental and pathological processes, including tissue regeneration, neuroprotection, and inflammation, all of which are crucial in SCI. The aim of this paper is to review the current understanding of the Wnt/β-catenin signaling pathway in the pathogenesis of SCI and its potential as a therapeutic target for improving recovery after SCI. The Wnt/β-catenin signaling pathway has a distinctive role in SCI pathogenesis, encompassing regulation of inflammation, apoptosis, glial scar, axonal repair and regeneration, and angiogenesis. Many treatment modalities, such as pharmaceutical administration, stem cell transplantation, gene therapy, electric stimulation, and the use of biomaterials and exosomes, exert beneficial effects in SCI animal models by interacting with the Wnt/β-catenin signaling pathway. The Wnt/β-catenin signaling pathway plays a multifaceted role in the pathogenesis of SCI and offers a promising avenue for therapeutic intervention. Its effects depend on the specific Wnt ligands involved, the injury stage, and t

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research